resiquimod has been researched along with lysophosphatidic acid in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (lysophosphatidic acid) | Trials (lysophosphatidic acid) | Recent Studies (post-2010) (lysophosphatidic acid) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 1,950 | 17 | 1,116 |
| Protein | Taxonomy | resiquimod (IC50) | lysophosphatidic acid (IC50) |
|---|---|---|---|
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.4998 | |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Homo sapiens (human) | 0.4709 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, IH; Chuang, YT; Hsieh, WC; Hsu, SC; Lai, MZ; Miaw, SC | 1 |
1 other study(ies) available for resiquimod and lysophosphatidic acid
| Article | Year |
|---|---|
Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap-/- mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; B-Cell CLL-Lymphoma 10 Protein; beta-Glucans; Candida albicans; Candidiasis; ErbB Receptors; Genetic Diseases, X-Linked; Humans; Imidazoles; Immunity, Innate; Inhibitor of Apoptosis Proteins; Lectins, C-Type; Lipopeptides; Lipopolysaccharides; Lymphoproliferative Disorders; Lysine; Lysophospholipids; Macrophages; Mice; NF-kappa B; Phagocytosis; Poly I-C; Protein Binding; Receptors, Antigen, T-Cell; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Ubiquitination | 2014 |